Assertive community treatment as part of integrated care versus standard care: a 12-month trial in patients with first- and multiple-episode schizophrenia spectrum disorders treated with quetiapine immediate release (ACCESS trial).
Beteiligte Einrichtungen
Abstract
The ACCESS trial examined the 12-month effectiveness of continuous therapeutic assertive community treatment (ACT) as part of integrated care compared to standard care in a catchment area comparison design in patients with schizophrenia spectrum disorders treated with quetiapine immediate release.
Bibliografische Daten
| Originalsprache | Deutsch |
|---|---|
| Aufsatznummer | 10 |
| ISSN | 0160-6689 |
| Status | Veröffentlicht - 2010 |
| pubmed | 20361911 |
|---|
